Clinical Trials Browser

Interventional × Breast Cancer Recurrent × Capecitabine × Clear all

NCT02947061 2016-10-31

S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer

Phase 2 Unknown

Breast Cancer Recurrent